Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.

Purpose Alternative mRNA splicing coupled to nonsense-mediated decay (NMD) is a common mRNA surveillance pathway also known to dynamically modulate gene expression in response to cellular stress. Here, we investigated the involvement of this pathway in the regulation of lysyl oxidase-like 1 (LOXL1) expression in response to pseudoexfoliation (PEX)-associated pathophysiologic factors. Methods Transcript levels of LOXL1 isoforms were determined in ocular tissues obtained from donor eyes without and with PEX syndrome. Pseudoexfoliation-relevant cell types, including human Tenon's capsule fibroblasts (hTCF) and trabecular meshwork cells (hTMC), were exposed to puromycin, caffeine, TGF-β1, homocysteine, IL-6, retinoic acid, UV-B radiation, oxidative stress, and mechanical stress for up to 48 hours. Western blot analysis was carried out using antibodies against LOXL1, (phosphorylated-) eukaryotic initiation factor 2-α (eIF2-α), and regulator of nonsense transcripts 2 (UPF2). RNA interference was used to knockdown UPF1-3 and Serine/threonine-protein kinase (SMG1). Results Constitutive expression of wild-type LOXL1 and alternatively spliced LOXL1-a transcripts was detected in all ocular tissues showing highest levels in trabecular meshwork and differential expression between PEX and control specimens. LOXL1-a transcripts were upregulated in hTCF and hTMC by NMD inhibitors puromycin and caffeine (≥6-fold; P < 0.01) or after knockdown of NMD core factors (≥2-fold; P < 0.05), whereas mRNA and protein levels of LOXL1 were reduced (≤0.8 fold; P < 0.05). Exposure of cells to various PEX-associated (stress) factors, including TGF-β1, UV-B light, oxidative stress, mechanical stress, and retinoic acid enhanced LOXL1-a transcript levels (≥1.5-fold; P < 0.05), while partially downregulating LOXL1 levels (≤0.7-fold; P < 0.05). Stress-induced inhibition of NMD was dependent on phosphorylation of eIF2α. Conclusions These findings provide evidence for a functional role of alternative splicing coupled to NMD in the posttranscriptional regulation of LOXL1 gene expression and suggest this mechanism to represent a dynamic mode of adapting LOXL1 expression to PEX-associated environmental and nutritional cues.

[1]  M. Hauser,et al.  lncRNAs, DNA Methylation, and the Pathobiology of Exfoliation Glaucoma , 2017, Journal of glaucoma.

[2]  W. Seeger,et al.  Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts. , 2017, Physiological genomics.

[3]  C. Gieger,et al.  Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1 , 2017, Nature Communications.

[4]  A. Robin,et al.  Association of Pseudoexfoliation With Systemic Vascular Diseases in a South Indian Population , 2017, JAMA ophthalmology.

[5]  P. Sommer,et al.  Methylation of LOXL1 Promoter by DNMT3A in Aged Human Skin Fibroblasts. , 2017, Rejuvenation research.

[6]  L. Lima,et al.  Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies , 2016, PloS one.

[7]  L. Pasquale,et al.  Exfoliation syndrome: assembling the puzzle pieces , 2016, Acta ophthalmologica.

[8]  N. Voelcker,et al.  Biological effect of LOXL1 coding variants associated with pseudoexfoliation syndrome. , 2016, Experimental eye research.

[9]  P. Trackman Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer , 2016, Expert opinion on therapeutic targets.

[10]  J. Cáceres,et al.  Mechanism and regulation of the nonsense-mediated decay pathway , 2016, Nucleic acids research.

[11]  Ping Liu,et al.  LOXL1 Gene Polymorphism With Exfoliation Syndrome/Exfoliation Glaucoma: A Meta-Analysis , 2016, Journal of glaucoma.

[12]  J. Erler,et al.  Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. , 2016, Cardiovascular research.

[13]  A. Viswanathan,et al.  Ethnicity‐Based Differences in the Association of LOXL1 Polymorphisms with Pseudoexfoliation/Pseudoexfoliative Glaucoma: A Meta‐Analysis , 2015, Annals of human genetics.

[14]  T. Jensen,et al.  Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes , 2015, Nature Reviews Molecular Cell Biology.

[15]  Dan Li,et al.  LOXL1 Hypermethylation in Pseudoexfoliation Syndrome in the Uighur Population. , 2015, Investigative ophthalmology & visual science.

[16]  G. Crawford,et al.  Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus. , 2015, Human molecular genetics.

[17]  H. Dietz,et al.  Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome. , 2015, Journal of molecular and cellular cardiology.

[18]  K. Baker,et al.  Nonsense‐mediated RNA decay – a switch and dial for regulating gene expression , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[19]  L. Pasquale,et al.  Exfoliation syndrome: a disease with an environmental component , 2015, Current opinion in ophthalmology.

[20]  J. E. Weigand,et al.  Hypoxia reduces MAX expression in endothelial cells by unproductive splicing , 2014, FEBS letters.

[21]  P. Kaufman,et al.  The trabecular meshwork in normal eyes and in exfoliation glaucoma. , 2014, Journal of glaucoma.

[22]  K. Tomizawa,et al.  Identification of a splicing variant that regulates type 2 diabetes risk factor CDKAL1 level by a coding-independent mechanism in human. , 2014, Human molecular genetics.

[23]  W. Seeger,et al.  Lysyl Oxidases Play a Causal Role in Vascular Remodeling in Clinical and Experimental Pulmonary Arterial Hypertension , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[24]  L. Pasquale,et al.  Consideration for Gene-Environment Interactions as Novel Determinants of Exfoliation Syndrome , 2014, International ophthalmology clinics.

[25]  M. Wilkinson,et al.  Regulation of nonsense-mediated mRNA decay: implications for physiology and disease. , 2013, Biochimica et biophysica acta.

[26]  G. Neufeld,et al.  The expression of lysyl‐oxidase gene family members in myeloproliferative neoplasms , 2013, American journal of hematology.

[27]  Yang Zhou,et al.  Expression and significance of lysyl oxidase-like 1 and fibulin-5 in the cardinal ligament tissue of patients with pelvic floor dysfunction , 2012, Journal of biomedical research.

[28]  D. Weiss,et al.  The role of lysyl oxidase family members in the stabilization of abdominal aortic aneurysms. , 2012, American journal of physiology. Heart and circulatory physiology.

[29]  U. Schlötzer-Schrehardt,et al.  [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?]. , 2012, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[30]  W. Willett,et al.  The Relationship between caffeine and coffee consumption and exfoliation glaucoma or glaucoma suspect: a prospective study in two cohorts. , 2012, Investigative ophthalmology & visual science.

[31]  Takako Sasaki,et al.  LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma. , 2012, Ophthalmology.

[32]  T. Schäffer,et al.  Evaluation of lamina cribrosa and peripapillary sclera stiffness in pseudoexfoliation and normal eyes by atomic force microscopy. , 2012, Investigative ophthalmology & visual science.

[33]  Seon-Young Kim,et al.  Variations in LOXL1 associated with exfoliation glaucoma do not affect amine oxidase activity , 2012, Molecular vision.

[34]  U. Schlötzer-Schrehardt,et al.  Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. , 2011, Investigative ophthalmology & visual science.

[35]  Anirudh Sethi,et al.  Transforming growth factor-beta induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. , 2011, Investigative ophthalmology & visual science.

[36]  L. Corcos,et al.  The emerging role of pre-messenger RNA splicing in stress responses: Sending alternative messages and silent messengers , 2011, RNA biology.

[37]  Emilie Lalonde,et al.  RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression. , 2011, Genome research.

[38]  J. Haines,et al.  LOXL1 promoter haplotypes are associated with exfoliation syndrome in a U.S. Caucasian population. , 2011, Investigative ophthalmology & visual science.

[39]  U. Schlötzer-Schrehardt Genetics and Genomics of Pseudoexfoliation Syndrome/Glaucoma , 2011, Middle East African journal of ophthalmology.

[40]  F. J. Moya,et al.  LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma , 2010, Molecular vision.

[41]  P. Lewczuk,et al.  Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. , 2010, The American journal of pathology.

[42]  M. Ramsay,et al.  Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population , 2010, Molecular vision.

[43]  R. Romero,et al.  A Single Nucleotide Polymorphism in the Promoter of the LOXL1 Gene and Its Relationship to Pelvic Organ Prolapse and Preterm Premature Rupture of Membranes , 2009, Reproductive Sciences.

[44]  U. Schlötzer-Schrehardt Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations. , 2009, Experimental eye research.

[45]  G. Naumann,et al.  Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. , 2008, The American journal of pathology.

[46]  Lawrence B. Gardner Hypoxic Inhibition of Nonsense-Mediated RNA Decay Regulates Gene Expression and the Integrated Stress Response , 2008, Molecular and Cellular Biology.

[47]  G. Pascual,et al.  Down-regulation of lysyl oxydase-like in aging and venous insufficiency. , 2008, Histology and histopathology.

[48]  Kari Stefansson,et al.  Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma , 2007, Science.

[49]  Angela N. Brooks,et al.  The coupling of alternative splicing and nonsense-mediated mRNA decay. , 2007, Advances in experimental medicine and biology.

[50]  G. Naumann,et al.  Ocular and systemic pseudoexfoliation syndrome. , 2006, American journal of ophthalmology.

[51]  G. Naumann,et al.  Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma. , 2005, Investigative ophthalmology & visual science.

[52]  J. Kornhuber,et al.  Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. , 2004, American journal of ophthalmology.

[53]  Jiangang Gao,et al.  Elastic fiber homeostasis requires lysyl oxidase–like 1 protein , 2004, Nature Genetics.

[54]  U. Schlötzer-Schrehardt,et al.  Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. , 2001, Experimental eye research.

[55]  Y. Taya,et al.  Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. , 2001, Genes & development.

[56]  K. Csiszȧr,et al.  Lysyl oxidases: a novel multifunctional amine oxidase family. , 2001, Progress in nucleic acid research and molecular biology.

[57]  D. Epstein,et al.  Genes upregulated in the human trabecular meshwork in response to elevated intraocular pressure. , 2000, Investigative ophthalmology & visual science.

[58]  H. Kagan,et al.  Lysyl oxidase: properties, regulation and multiple functions in biology. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[59]  M. Carter,et al.  A Regulatory Mechanism That Detects Premature Nonsense Codons in T-cell Receptor Transcripts in Vivo Is Reversed by Protein Synthesis Inhibitors in Vitro* , 1995, The Journal of Biological Chemistry.

[60]  H. Taylor The environment and the lens. , 1980, The British journal of ophthalmology.